rs200174262

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_001365536.1(SCN9A):​c.2005C>T​(p.Arg669Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000893 in 1,612,396 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R669H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00034 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000064 ( 0 hom. )

Consequence

SCN9A
NM_001365536.1 missense

Scores

8
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 0.232
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.030504197).
BP6
Variant 2-166281778-G-A is Benign according to our data. Variant chr2-166281778-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 449780.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Likely_benign=2}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN9ANM_001365536.1 linkc.2005C>T p.Arg669Cys missense_variant Exon 13 of 27 ENST00000642356.2 NP_001352465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN9AENST00000642356.2 linkc.2005C>T p.Arg669Cys missense_variant Exon 13 of 27 NM_001365536.1 ENSP00000495601.1 Q15858-1
SCN9AENST00000303354.11 linkc.2005C>T p.Arg669Cys missense_variant Exon 13 of 27 5 ENSP00000304748.7 Q15858-1
SCN9AENST00000409672.5 linkc.1972C>T p.Arg658Cys missense_variant Exon 13 of 27 5 ENSP00000386306.1 Q15858-3
SCN9AENST00000645907.1 linkc.1972C>T p.Arg658Cys missense_variant Exon 13 of 27 ENSP00000495983.1 Q15858-4
SCN9AENST00000454569.6 linkc.1972C>T p.Arg658Cys missense_variant Exon 13 of 15 1 ENSP00000413212.2 A0A0C4DG82

Frequencies

GnomAD3 genomes
AF:
0.000336
AC:
51
AN:
151924
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00116
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000480
GnomAD2 exomes
AF:
0.000117
AC:
29
AN:
247644
AF XY:
0.0000968
show subpopulations
Gnomad AFR exome
AF:
0.00142
Gnomad AMR exome
AF:
0.0000292
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000356
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000637
AC:
93
AN:
1460354
Hom.:
0
Cov.:
30
AF XY:
0.0000496
AC XY:
36
AN XY:
726410
show subpopulations
Gnomad4 AFR exome
AF:
0.00105
AC:
35
AN:
33394
Gnomad4 AMR exome
AF:
0.0000672
AC:
3
AN:
44642
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
26086
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39606
Gnomad4 SAS exome
AF:
0.0000581
AC:
5
AN:
86082
Gnomad4 FIN exome
AF:
0.00
AC:
0
AN:
53260
Gnomad4 NFE exome
AF:
0.0000378
AC:
42
AN:
1111210
Gnomad4 Remaining exome
AF:
0.000133
AC:
8
AN:
60318
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000335
AC:
51
AN:
152042
Hom.:
0
Cov.:
32
AF XY:
0.000323
AC XY:
24
AN XY:
74316
show subpopulations
Gnomad4 AFR
AF:
0.00116
AC:
0.00115702
AN:
0.00115702
Gnomad4 AMR
AF:
0.00
AC:
0
AN:
0
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 FIN
AF:
0.00
AC:
0
AN:
0
Gnomad4 NFE
AF:
0.0000294
AC:
0.0000294187
AN:
0.0000294187
Gnomad4 OTH
AF:
0.000475
AC:
0.000474834
AN:
0.000474834
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000250
Hom.:
0
Bravo
AF:
0.000427
ESP6500AA
AF:
0.00134
AC:
5
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000124
AC:
15

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jul 08, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.R658C variant (also known as c.1972C>T), located in coding exon 12 of the SCN9A gene, results from a C to T substitution at nucleotide position 1972. The arginine at codon 658 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is not well conserved in available vertebrate species, and cysteine is the reference amino acid in other vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the supporting evidence, this variant is unlikely to be causative of primary erythermalgia/small fiber neuropathy and paroxysmal extreme pain disorder (PEPD); however, its contribution to the development of congenital insensitivity to pain (CIP) and hereditary sensory autonomic neuropathy type II (HSAN2D) is uncertain. -

not provided Uncertain:1
Nov 23, 2022
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

not specified Benign:1
Jun 18, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: SCN9A c.1972C>T (p.Arg658Cys) results in a non-conservative amino acid change located in the Voltage-gated Na+ ion channel, cytoplasmic domain (IPR024583) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00012 in 247644 control chromosomes, predominantly at a frequency of 0.0014 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 1 fold of the estimated maximal expected allele frequency for a pathogenic variant in SCN9A causing Channelopathy-Associated Congenital Insensitivity To Pain, Autosomal Recessive phenotype (0.0011). To our knowledge, no occurrence of c.1972C>T in individuals affected with Channelopathy-Associated Congenital Insensitivity To Pain, Autosomal Recessive and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 449780). Based on the evidence outlined above, the variant was classified as likely benign. -

Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Uncertain
0.030
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.79
.;D;.;.;D;.;.
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.45
FATHMM_MKL
Benign
0.43
N
LIST_S2
Benign
0.42
T;.;T;T;T;T;T
M_CAP
Benign
0.054
D
MetaRNN
Benign
0.031
T;T;T;T;T;T;T
MetaSVM
Uncertain
0.57
D
MutationAssessor
Uncertain
2.8
.;M;.;.;M;M;.
PrimateAI
Benign
0.35
T
PROVEAN
Uncertain
-3.8
D;D;.;.;.;D;.
REVEL
Uncertain
0.38
Sift
Benign
0.032
D;D;.;.;.;D;.
Sift4G
Uncertain
0.023
D;D;.;.;.;D;.
Polyphen
0.014
.;B;.;.;B;.;.
Vest4
0.42
MVP
0.81
MPC
0.17
ClinPred
0.071
T
GERP RS
2.7
Varity_R
0.14
gMVP
0.46
Mutation Taster
=61/39
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200174262; hg19: chr2-167138288; API